GAIN THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.28 USD | +2.40% |
|
-0.78% | -60.80% |
| 06-28 | Sector Update: Health Care Stocks Higher Pre-Bell Friday | MT |
| 06-27 | Gain Therapeutics Names Gene Mack as Interim Chief Executive Officer | MT |
Chart calendar Gain Therapeutics, Inc.
74.4QPDGaG196bCXJCL2MUX-P1dwhZHFAX22OFYMHD3RBc.lUyzW8_RvvmyM_bB6JJEz8o1-y89RkTGiYMRYjSCM1umMJt4l-aR8bI7_w~96828c041f935d2a5e285dcb61125e17
Upcoming events on Gain Therapeutics, Inc.
Past events on Gain Therapeutics, Inc.
| 27/06/2024 12:00 | H.C Wainwright Neuro Perspectives Virtual Conference |
| 24/06/2024 13:30 | Annual General Meeting |
| 14/05/2024 12:30 | Q1 2024 Earnings Release |
| 26/03/2024 12:00 | Q4 2023 Earnings Release |
| 22/02/2024 16:00 | Investor Meeting - Key Opinion Leader |
| 09/02/2024 16:00 | WORLD Symposium |
| 06/12/2023 21:30 | AI Driven Drug Discovery Summit - Panel |
| 05/12/2023 17:00 | FORCE Family Office Healthcare Conference |
| 14/11/2023 12:00 | Q3 2023 Earnings Release |
| 28/09/2023 17:40 | Cantor Global Healthcare Conference - Fireside Chat |
| 26/09/2023 13:35 | Cambridge Healthtech Institute Neurodegeneration Targets Conference |
| 30/08/2023 12:00 | Parkinson Disease and Movement Disorders International Congress - Abstract Number #1376 |
| 27/08/2023 12:00 | Parkinson Disease and Movement Disorders International Congress - Abstract Number #LBA-13 |
| 26/08/2023 | Parkinson Disease and Movement Disorders International Congress - Abstract Number #1376 |
| 10/08/2023 12:00 | Q2 2023 Earnings Release |
| 08/08/2023 14:30 | BTIG Virtual Biotechnology Conference |
| 23/06/2023 13:30 | Annual General Meeting |
| 21/06/2023 20:00 | Maxim Group Virtual Healthcare Conference |
| 07/06/2023 21:30 | Jefferies Global Healthcare Conference |
| 13/05/2023 | Lysosomal Diseases Gordon Research Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,03 | 0,16 0,15 10.73% | 0,14 0,12 19.24% | 0,06 0,30 -81.85% | 0,60 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -13,8 -16,5 16.22% | -17,8 -18,2 2.11% | -22,3 -22,8 2.31% | -19,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -13,9 -16,5 15.73% | -17,5 -17,9 1.99% | -22,2 -22,4 0.78% | -18,4 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -13,9 -16,5 15.74% | -17,6 -17,9 1.53% | -22,3 -22,4 0.68% | -18,5 |
|
EPS USD | Released Forecast Spread | -1,17 | -1,37 -1,62 15.61% | -1,48 -1,51 1.82% | -1,71 -1,57 -8.74% | -0,97 |
| Announcement Date | 15/03/21 | 24/03/22 | 23/03/23 | 26/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,05 0,04 15.41% | 0,10 0,04 167.89% | 0,00 0,06 - | 0,00 0,01 - | 0,06 0,01 451.8% | 0,00 1,01 - | 0,00 0,09 - | 0,00 0,26 - | 0,00 0,09 - | 0,24 | 0,05 | 0,05 | 0,15 | 0,10 |
|
EBIT Million USD | Released Forecast Spread | -3,29 -4,29 23.37% | -5,18 -3,73 -38.7% | -4,75 -5,26 9.73% | -4,56 -5,00 8.75% | -5,23 -4,78 -9.41% | -7,73 -3,87 -99.76% | -4,89 -6,09 19.76% | -4,41 -4,93 10.69% | -4,38 -5,17 15.32% | -4,24 | -5,09 | -5,28 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,27 -4,10 20.22% | -5,08 -3,75 -35.23% | -4,55 -5,54 17.73% | -4,60 -4,90 6.24% | -5,12 -4,78 -7.22% | -7,66 -3,79 -102.34% | -4,70 -6,02 21.97% | -4,71 -4,88 3.58% | -3,99 -5,05 20.94% | -4,17 | -5,03 | -5,21 | ||
|
Net income Million USD | Released Forecast Spread | -3,27 -4,10 20.13% | -5,09 -3,75 -35.48% | -4,56 -5,54 17.7% | -4,67 -4,90 4.67% | -5,14 -4,60 -11.61% | -7,69 -3,79 -102.69% | -4,72 -6,04 21.82% | -4,72 -4,88 3.14% | -4,01 -4,53 11.35% | -4,18 | -5,04 | -5,22 | ||
|
EPS USD | Released Forecast Spread | -0,28 -0,37 23.81% | -0,43 -0,31 -37.24% | -0,38 -0,46 17.39% | -0,39 -0,38 -3.31% | -0,43 -0,39 -9.32% | -0,62 -0,31 -101.63% | -0,37 -0,46 20.14% | -0,29 -0,33 13.17% | -0,22 -0,30 26.05% | -0,23 | -0,26 | -0,26 | -0,28 | -0,28 |
| Announcement Date | 16/05/22 | 08/08/22 | 10/11/22 | 23/03/23 | 12/05/23 | 10/08/23 | 14/11/23 | 26/03/24 | 14/05/24 | - | - | - | - | - |
| 15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release |
| 23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 06:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 25/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 26/07/2024 06:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Gain Therapeutics, Inc.
| 07/06/2024 07:57 | POLARIS GROUP: May 2024 Sales and Revenue Release |
| 29/05/2024 21:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 23/05/2024 12:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 06:00 | EVOTEC SE: Q1 2024 Earnings Release |
| 21/05/2024 22:14 | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 12:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 15/05/2024 21:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- GANX Stock
- Calendar Gain Therapeutics, Inc.
